Cancer Family
Connective and Soft Tissue Neoplasm
CI-CAN-00000010Explore in graph →
Non-malignant848 active trials17 approved drugs339 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000010Explore in graph →
Clinical trials
3,876 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07560709 | Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma | no longer available | — | — | University of FloridaOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT03874455 | Tazemetostat Expanded Access Program for Adults With Solid Tumors | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT04225429 | Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT03493152 | Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019) | no longer available | — | — | The University of Texas Health Science Center at San AntonioOTHER | 0 | May 28, 2025 | clinicaltrials |
| NCT03493165 | Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020) | no longer available | — | — | The University of Texas Health Science Center at San AntonioOTHER | 0 | May 28, 2025 | clinicaltrials |
| NCT03941782 | Compassionate Use of BYL 719 Alpelisib | no longer available | — | — | New Mexico Cancer Research AllianceOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02822495 | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies | no longer available | — | — | Atara BiotherapeuticsINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
| NCT03029481 | Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma | no longer available | — | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Mar 28, 2019 | clinicaltrials |
| NCT02955446 | Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies | no longer available | — | — | University of Colorado, DenverOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT00210665 | A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment | no longer available | — | — | Janssen Research & Development, LLCINDUSTRY | 3 | Oct 10, 2017 | clinicaltrials |
| NCT03085186 | Treatment With Crizotinib Single Patient Expanded Access IND 134375 | no longer available | — | — | Jean M. Tersak, M.D.OTHER | 0 | Aug 29, 2017 | clinicaltrials |
| NCT02712567 | SARC021C: A Continuation Study of TH-CR-406/SARC021 | no longer available | — | — | Sarcoma Alliance for Research through CollaborationOTHER | 0 | Oct 13, 2016 | clinicaltrials |
| NCT01689376 | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program) | no longer available | — | — | BayerINDUSTRY | 0 | Aug 16, 2016 | clinicaltrials |
| NCT02570412 | Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy | no longer available | — | — | CytRxINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01613053 | Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination(MACS2226) | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT01646593 | Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy | no longer available | — | — | BayerINDUSTRY | 0 | Dec 15, 2014 | clinicaltrials |
| NCT01427582 | YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access | no longer available | — | — | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 1, 2011 | clinicaltrials |
Data updated 4 days agoSource updated Sep 23, 2026source: clinicaltrials